Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial—results from the Scleroderma Lung Study

Objective. Scleroderma Lung Study (SLS) showed that cyclophosphamide (CYC) was better than placebo (PLA) in preventing progression of forced vital capacity percentage (FVC%) predicted and dyspnoea at 12 months. Our objective was to assess minimally important difference (MID) for Mahler's Transi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Khanna, Dinesh, Tseng, Chi-Hong, Furst, Daniel E., Clements, Philip J., Elashoff, Robert, Roth, Michael, Elashoff, David, Tashkin, Donald P.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2009
Assuntos:
Clinical
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2777487/
https://ncbi.nlm.nih.gov/pubmed/19776222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kep284
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados